ETST on OTC
Earth Science Tech, Inc.
American pharmaceutical preparations company based in Miami. Summary from the record
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with Verrica Pharmaceuticals Inc., Sunshine Biopharma Inc. or LFTD PARTNERS INC., or pick any stock.
- TickerETST on OTC2
- IndustryPharmaceutical Preparations2
- HeadquartersNewark, United States2
- Incorporated inFL4
- Business address8950 Sw 74Th Ct, Suite 101, Miami, Fl 331564
- Filer categoryNon-accelerated filer, Smaller reporting company4
- Legal formCorporation2
- LEI5493005PQQBQWR41CT232
- StatusActive2
- LEI statusLapsed (not renewed)2
- Registered addressC/O Nevada Business Center, LLC, 89703 Carson City, United States2
See how the biggest companies compare on our leaderboards
23, 2010, and subsequently redomiciled to the State of Florida on June 27, 2022, headquartered in Miami, Florida.5 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2026
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Sale of Pharmaceutical Products and Medical Consultations brought in 92% of the revenue Earth Science Tech, Inc. broke down this way in fiscal 2026.
Products and services by year
| Products and services | 2025 | 2026 |
|---|---|---|
| Sale of Pharmaceutical Products and Medical Consultations | $30.0M | $32.9M |
| Shipping and Handling | $3.1M | $2.5M |
| Other. | $300.8K |
Where the money goes
Where each dollar of revenue went, fiscal 2026
- Cost of revenue29¢$10.2M
- Selling, general and admin10¢$3.6M
- Other costs50¢$17.8M
- Income tax1¢$511.7K
- Profit10¢$3.6M
Out of $35.7M in revenue.3
Where each dollar of operating cash went, fiscal 2026
- Capital spending39¢$756.6K
- Share buybacks24¢$471.4K
- Kept or used elsewhere37¢$712.8K
Out of $1.9M of cash from operations.3
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.3
| Period ending | 2026-03-31 | 2025-03-31 |
|---|---|---|
| Revenue | $35.7M | $33.1M |
| Cost of Goods Sold | $10.2M | $8.8M |
| Gross Profit | $25.5M | $24.3M |
| Salaries Expense | $13.8M | $14.1M |
| Selling general and administrative expenses | $3.6M | $4.2M |
| Bank charges | $1.0M | $1.1M |
| Advertising & marketing | $2.8M | $836.9K |
| Legal and professional fees | $221.2K | $305.9K |
| Insurance | $168.4K | $180.3K |
| Operating lease cost | $180.8K | $98.4K |
| Depreciation and amortization | $284.4K | $54.0K |
| Utilities | $130.8K | $39.7K |
| Total Expenses | $22.2M | $20.9M |
| Dividend and interest income | $15.5K | $9.1K |
| Net realized gain on sale of investments | $671.5K | $300.2K |
| Unrealized Gain (Loss) on fair value changes of investments | -$957.1K | -$365.7K |
| Other | $67.2K | |
| Interest Expense | -$16.3K | -$21.2K |
| Net Income before taxes | $3.1M | $3.4M |
| Income Taxes | -$511.7K | $116.8K |
| Net Income | $3.6M | $3.3M |
| Net Income/(Loss) attributed to non-controlling interest | -$29.8K | |
| Net Income available to common stockholders | $3.6M | $3.3M |
| Earnings per common share - Basic | $0.01 | $0.01 |
| Earnings per common share - Diluted | $0.01 | $0.01 |
| Weighted average number of shares outstanding- Basic | 293.1M shares | 303.5M shares |
| Weighted average number of shares outstanding- Diluted | 293.1M shares | 303.5M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.3
| Period ending | 2026-03-31 | 2025-03-31 | 2024-03-31 |
|---|---|---|---|
| Cash and cash equivalents | $796.8K | $1.5M | |
| Accounts receivable, net | $356.1K | $129.1K | |
| Equity securities | $1.4M | $645.4K | |
| Inventory | $682.1K | $503.9K | |
| Long lived assets, available for sale | $371.7K | ||
| Prepaid Expenses and other current assets | $154.5K | $358.8K | |
| Total Current Assets | $3.7M | $3.1M | |
| Property and Equipment, net | $1.5M | $1.4M | |
| Right of use assets, net | $95.3K | $172.4K | |
| Intangible assets, net | $208.2K | $96.9K | |
| Deferred tax asset, net | $772.3K | ||
| Goodwill | $2.7M | $2.3M | |
| TOTAL ASSETS | $9.0M | $7.1M | |
| Accounts payable | $681.9K | $492.4K | |
| Accrued expenses and other payables | $1.2M | $2.3M | |
| Current portion of operating lease obligations | $96.2K | $121.9K | |
| Current portion of loans & obligations | $30.6K | ||
| Short-term business loans | $179.5K | ||
| Total Current Liabilities | $1.9M | $3.1M | |
| Lease Liability | $37.9K | ||
| Loans and Obligations | $31.4K | ||
| Total Liabilities | $1.9M | $3.2M | |
| Preferred stock, par value $0.001 per share, 1,000,000 shares authorized; 1,000,000 and 1,000,000 shares issued and outstanding as of March 31, 2026, and March 31, 2025, respectively | $1.0K | $1.0K | |
| Common stock, par value $0.001 per share, 300,000,000 shares authorized; 291,324,607 shares issued and outstanding as of March 31, 2026, and 295,347,903 issued and 294,302,607 outstanding as of March 31, 2025 | $291.3K | $295.3K | |
| Additional Paid in Capital | $30.8M | $31.5M | |
| Accumulated Deficit | -$24.1M | -$27.7M | |
| Treasury Stock, at cost (0 and 1,045,296 shares as of March 31, 2026, and March 31, 2025, respectively) | -$186.4K | ||
| Total Stockholders Equity | $7.0M | $3.9M | $2.2M |
| Non-Controlling Interest | $30.3K | ||
| Total Equity | $7.0M | $3.9M | |
| TOTAL LIABILITIES AND EQUITY | $9.0M | $7.1M | |
| Preferred stock, par value | $0.00 | $0.00 | |
| Preferred stock, shares authorized | 1.0M shares | 1.0M shares | |
| Preferred stock, shares issued | 1.0M shares | 1.0M shares | |
| Preferred stock, shares outstanding | 1.0M shares | 1.0M shares | |
| Common stock, par value | $0.00 | $0.00 | |
| Common stock, shares authorized | 300.0M shares | 300.0M shares | |
| Common stock, shares issued | 291.3M shares | 295.3M shares | |
| Common stock, shares outstanding | 291.3M shares | 294.3M shares | |
| Treasury common shares | 0 shares | 1.0M shares |
| Period ending | 2026-03-31 | 2025-03-31 | 2024-03-31 |
|---|---|---|---|
| Cash and cash equivalents | $796.8K | $1.5M | |
| Accounts receivable, net | $356.1K | $129.1K | |
| Equity securities | $1.4M | $645.4K | |
| Inventory | $682.1K | $503.9K | |
| Long lived assets, available for sale | $371.7K | ||
| Prepaid Expenses and other current assets | $154.5K | $358.8K | |
| Total Current Assets | $3.7M | $3.1M | |
| Property and Equipment, net | $1.5M | $1.4M | |
| Right of use assets, net | $95.3K | $172.4K | |
| Intangible assets, net | $208.2K | $96.9K | |
| Deferred tax asset, net | $772.3K | ||
| Goodwill | $2.7M | $2.3M | |
| TOTAL ASSETS | $9.0M | $7.1M | |
| Accounts payable | $681.9K | $492.4K | |
| Accrued expenses and other payables | $1.2M | $2.3M | |
| Current portion of operating lease obligations | $96.2K | $121.9K | |
| Current portion of loans & obligations | $30.6K | ||
| Short-term business loans | $179.5K | ||
| Total Current Liabilities | $1.9M | $3.1M | |
| Lease Liability | $37.9K | ||
| Loans and Obligations | $31.4K | ||
| Total Liabilities | $1.9M | $3.2M | |
| Preferred stock, par value $0.001 per share, 1,000,000 shares authorized; 1,000,000 and 1,000,000 shares issued and outstanding as of March 31, 2026, and March 31, 2025, respectively | $1.0K | $1.0K | |
| Common stock, par value $0.001 per share, 300,000,000 shares authorized; 291,324,607 shares issued and outstanding as of March 31, 2026, and 295,347,903 issued and 294,302,607 outstanding as of March 31, 2025 | $291.3K | $295.3K | |
| Additional Paid in Capital | $30.8M | $31.5M | |
| Accumulated Deficit | -$24.1M | -$27.7M | |
| Treasury Stock, at cost (0 and 1,045,296 shares as of March 31, 2026, and March 31, 2025, respectively) | -$186.4K | ||
| Total Stockholders Equity | $7.0M | $3.9M | $2.2M |
| Non-Controlling Interest | $30.3K | ||
| Total Equity | $7.0M | $3.9M | |
| TOTAL LIABILITIES AND EQUITY | $9.0M | $7.1M | |
| Preferred stock, par value | $0.00 | $0.00 | |
| Preferred stock, shares authorized | 1.0M shares | 1.0M shares | |
| Preferred stock, shares issued | 1.0M shares | 1.0M shares | |
| Preferred stock, shares outstanding | 1.0M shares | 1.0M shares | |
| Common stock, par value | $0.00 | $0.00 | |
| Common stock, shares authorized | 300.0M shares | 300.0M shares | |
| Common stock, shares issued | 291.3M shares | 295.3M shares | |
| Common stock, shares outstanding | 291.3M shares | 294.3M shares | |
| Treasury common shares | 0 shares | 1.0M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.3
| Period ending | 2026-03-31 | 2025-03-31 |
|---|---|---|
| Net Income | $3.6M | $3.3M |
| Depreciation and amortization | $284.4K | $54.0K |
| Unrealized loss on investments | $957.1K | $365.7K |
| Realized gain on sale of investments | -$671.5K | -$300.2K |
| Accounts receivable | -$227.0K | $106.4K |
| Prepaid expenses and other current assets | -$120.8K | -$349.5K |
| Inventory | -$141.5K | -$188.2K |
| Deferred tax asset | -$772.3K | |
| Accounts payable and accrued expenses and other | -$968.4K | $1.4M |
| Net cash provided by operating activities | $1.9M | $4.4M |
| Purchases of property and equipment, intangibles and long-lived assets available for sale | -$756.6K | -$753.2K |
| Purchase of investments | -$7.6M | -$4.3M |
| Sale of investments | $6.6M | $3.6M |
| Cash used for assets acquisition, net of cash acquired | -$147.6K | -$417.2K |
| Net cash used in investing activities | -$1.9M | -$1.9M |
| Payments on loans and obligations | -$241.5K | -$429.1K |
| Proceeds from loan payable | $179.5K | |
| Repurchase of common stock | -$471.4K | -$1.5M |
| Net Cash used in financing activities | -$712.9K | -$1.7M |
| Net increase (decrease) in cash and cash equivalents | -$676.4K | $775.5K |
| Cash paid for interest | $16.3K | $21.2K |
| Cash paid for income taxes | $152.6K | $28.3K |
| Initial recognition of right of use asset | $104.9K | $100.3K |
No quarter-by-quarter statement was filed.
Leadership
Who has led Earth Science Tech, Inc., and when. Pick a name to see everywhere that person has worked.
Chief financial officer
Chief operating officer
- Chief executive officerGiorgio R. Saumat Feb 17, 2023 to now15
- Chief executive officerMichel Aube Dec 6, 2018 to Dec 6, 201816
- Chief executive officerMatthew Cohen May 19, 2015 to May 19, 201517
- Chief executive officerHarvey Katz Dec 31, 2014 to Dec 31, 201418
- ChairNickolas Salomon Tabraue Dec 6, 2018 to Dec 6, 201819
- PresidentNickolas Salomon Tabraue Dec 6, 2018 to Dec 6, 201819
- PresidentHarvey Katz Mar 30, 2015 to Mar 30, 201520
- PresidentIssa El-Cheikh Apr 16, 2014 to Apr 16, 201421
- Chief financial officerErnesto L. Flores May 21, 2024 to now22
- Chief financial officerWendell Hecker Dec 6, 2018 to Dec 6, 201823
- Chief financial officerMatthew Cohen May 19, 2015 to May 19, 201517
- Chief operating officerMario Guillermo Tabraue May 8, 2024 to now24
- Chief operating officerGregg Gagan Hunter Dec 6, 2018 to Dec 6, 201825
- Chief operating officerThomas H. Wright May 27, 2015 to May 27, 201526
Board members and other officers (12)
- Independent DirectorEmiliano Curia Jan 22, 2025 to now27
- Chief Technology OfficerChristopher Alan Rose Apr 30, 2024 to now28
- Chief Sales OfficerDavid Barbash May 9, 2019 to May 9, 201929
- Board memberErnesto L. Flores Jan 28, 2025 to now30
- Board memberMario Guillermo Tabraue May 8, 2024 to now24
- Board memberJeff P. H. Cazeau Jul 24, 2024 to now31
- Board memberYovan Arturo Sanchez Dec 12, 2023 to now32
- Board memberGiorgio R. Saumat Nov 22, 2022 to now33
- Board memberGregg Gagan Hunter Dec 6, 2018 to Dec 6, 201825
- Board memberHarvey Katz Mar 30, 2015 to Mar 30, 201520
- Board memberThomas H. Wright May 27, 2015 to May 27, 201526
- Board memberIssa El-Cheikh Apr 16, 2014 to Apr 16, 201421
Former names
- Ultimate Novelty Sports Inc.Feb 1, 2012 to Apr 17, 20144
Timeline
Filings
219 filings to the SEC since October 2021: 8 annual reports, 18 quarterly reports, 65 major events, 108 insider forms, 3 large holders, 3 private raises, 14 other. The latest 20:
- Sep 1, 20268-K EDGAR
- Aug 19, 20268-K EDGAR
- Aug 12, 20268-K EDGAR
- Aug 7, 20268-K EDGAR
- Aug 7, 202610-Q EDGAR
- Jul 29, 2026DEF 14A EDGAR
- Jul 20, 2026PRER14A EDGAR
- Jul 2, 2026PRE 14A EDGAR
- Jun 22, 2026SCHEDULE 13G EDGAR
- Jun 18, 20268-K EDGAR
- Jun 18, 202610-K EDGAR
- Jun 10, 20268-K EDGAR
- Apr 17, 20268-K EDGAR
- Mar 24, 20268-K EDGAR
- Mar 13, 20268-K EDGAR
- Feb 20, 20268-K EDGAR
- Feb 17, 20268-K EDGAR
- Feb 13, 202610-Q EDGAR
- Jan 6, 20268-K EDGAR
- Jan 5, 20268-K EDGAR
The 219 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
117 open-market trades by officers, directors and large owners since October 2021: 117 buys and 0 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jul 22, 2025 | Saumat Giorgio R.CEO | Buy | 50,000 | $0.21 | $10.5K | Form 4 |
| Jul 21, 2025 | Saumat Giorgio R.CEO | Buy | 100,000 | $0.20 | $20.0K | Form 4 |
| Jul 9, 2025 | Sanchez Yovan ArturoDirector | Buy | 21,939 | $0.18 | $3.9K | Form 4 |
| Jul 8, 2025 | Sanchez Yovan ArturoDirector | Buy | 11,105 | $0.18 | $2.0K | Form 4 |
| Jul 2, 2025 | Sanchez Yovan ArturoDirector | Buy | 60,805 | $0.20 | $12.2K | Form 4 |
| Mar 14, 2025 | Sanchez Yovan ArturoDirector | Buy | 100,000 | $0.12 | $12.0K | Form 4 |
| Mar 10, 2025 | Tabraue Mario GuillermoCOO | Buy | 40,000 | $0.14 | $5.6K | Form 4 |
| Mar 4, 2025 | Rose Christopher AlanCTO | Buy | 31,500 | $0.16 | $4.9K | Form 4 |
| Feb 24, 2025 | Saumat Giorgio R.CEO | Buy | 100,000 | $0.18 | $18.0K | Form 4 |
| Jan 31, 2025 | Sanchez Yovan ArturoDirector | Buy | 100,000 | $0.18 | $18.0K | Form 4 |
| Jan 28, 2025 | Flores Ernesto LCFO | Buy | 43,478 | $0.23 | $10.0K | Form 4 |
| Jan 24, 2025 | Tabraue Mario GuillermoCOO | Buy | 20,000 | $0.23 | $4.6K | Form 4 |
| Jan 16, 2025 | Saumat Giorgio R.CEO | Buy | 783,100 | $0.20 | $155.6K | Form 4 |
| Jan 8, 2025 | Cazeau Jeff P. H. | Buy | 72,555 | $0.15 | $10.8K | Form 4 |
| Jan 7, 2025 | Cazeau Jeff P. H. | Buy | 79,200 | $0.12 | $9.5K | Form 4 |
| Jan 7, 2025 | Cazeau Jeff P. H. | Buy | 79,200 | $0.12 | $9.5K | Form 4 |
| Jan 2, 2025 | Saumat Giorgio R.CEO | Buy | 3,800 | $0.13 | $494 | Form 4 |
| Jan 2, 2025 | Sanchez Yovan ArturoDirector | Buy | 56,151 | $0.12 | $6.7K | Form 4 |
| Dec 27, 2024 | Saumat Giorgio R.CEO | Buy | 600 | $0.14 | $84 | Form 4 |
| Dec 12, 2024 | Sanchez Yovan ArturoDirector | Buy | 100,000 | $0.12 | $12.0K | Form 4 |
All 117 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Giorgio R. SaumatSCHEDULE 13G, 1 filing Jun 22, 202634
- Mario PortelaSC 13G, 1 filing Dec 21, 202235
- Jose Damian RodriguezSC 13G, 1 filing Dec 13, 202236
Money raised
Private offerings the company reported to the SEC on Form D.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16SEC EDGARMichel Aube, Chief executive officer
- 17
- 18SEC EDGARHarvey Katz, Chief executive officer
- 19SEC EDGARNickolas Salomon Tabraue, Chair
- 20SEC EDGARHarvey Katz, President
- 21SEC EDGARIssa El-Cheikh, President
- 22
- 23
- 24
- 25
- 26
- 27SEC EDGAREmiliano Curia, Independent Director
- 28
- 29SEC EDGARDavid Barbash, Chief Sales Officer
- 30SEC EDGARErnesto L. Flores, Board member
- 31SEC EDGARJeff P. H. Cazeau, Board member
- 32SEC EDGARYovan Arturo Sanchez, Board member
- 33SEC EDGARGiorgio R. Saumat, Board member
- 34
- 35
- 36